McNeil
This article was originally published in The Tan Sheet
Executive Summary
Firm agrees to acquire the technology for the Nicotrol nicotine patch along with a number of other drug delivery systems from Cygnus for up to $75 mil. in cash. McNeil Consumer Healthcare markets Nicotrol in the U.S. Cygnus is retaining the assets related to a nicotine patch under development and one other early stage product